CLU and atrial fibrillation: Therefore, it is necessary to conduct future research in a larger study population with a longer follow-up period to certainly confirm the possibility of using Apo-J as a predictive plasma biomarker of the long-term effectiveness of cryoablation (no recurrence of AF), which in the future could be used as a non-invasive marker in clinical practice.